Main Textbook of Neurointensive Care: Volume 2: Perioperative Management, Monitoring, Pharmacotherapy

Textbook of Neurointensive Care: Volume 2: Perioperative Management, Monitoring, Pharmacotherapy

, , , , , ,
5.0 / 5.0
0 comments
This extensively updated edition provides a comprehensive review of intensive care for neurologically injured patients from the emergency room and ICU through the operating room and post-surgical period in two comprehensive volumes. The Editors of this second volume present a comprehensive textbook that incorporates best practice/evidence-based medicine and performance improvement, while it champions the three characteristics needed in our neuro–ICUs: patient and family centered high-quality care, education, and discovery. This volume concentrates on perioperative management, monitoring and pharmacotherapy, examining the neurological problems most frequently seen in intensive care, and describes the various types of neurosurgery and critical features of the management of patients. General issues are discussed across the textbook, such as cardiac care, fluids and electrolytes, nutrition, and monitoring as well as more specific conditions and complications including elevated intracranial pressure, seizures, and altered mental states.Listening to an injured brain is not easy. It takes knowledge, dedication, and understanding of the critically ill patient and their family. Textbook of Neurointensive Care Volume 2: Perioperative Management, Monitoring, Pharmacotherapy provides the reader with a detailed resource for studying this most complex area of medicine. It is thus essential reading for all trainees and professionals in critical care, neurosurgery, anesthesia and neurology.
Request Code : ZLIBIO4424009
Categories:
Year:
2024
Publisher:
Springer; Third Edition 2024
Language:
English
Pages:
493
ISBN 10:
3031622235
ISBN 13:
9783031622236
ISBN:
3031622235,9783031622236
This book is not available due to the complaint of the copyright holder.

Comments of this book

There are no comments yet.